Dixon Robert L JR

SEC Form 4 insider trading activity

Dixon Robert L JR has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including OKTA, ELV, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.

On the most recent filing, Dixon Robert L JR is listed as Director at Elevance Health, Inc. Inside the rolling window, Dixon Robert L JR reported no open-market purchases and 1 open-market sale totaling $61K in ELV.

Companies traded

Other insiders at OKTA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$61K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ELV
Dixon Robert L JR
Sale$61KJun 12SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Dixon Robert L JR made?

Dixon Robert L JR has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including OKTA, ELV since 2026.

Which companies does Dixon Robert L JR trade?

Dixon Robert L JR has filed SEC Form 4 disclosures for 2 companies, including OKTA, ELV.

When was Dixon Robert L JR's most recent SEC Form 4 filing?

Dixon Robert L JR's most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.

What is Dixon Robert L JR's total buy and sell value in the current window?

Inside the rolling retention window, Dixon Robert L JR bought $0 and sold $61K based on SEC Form 4 filings.

What was Dixon Robert L JR's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 151 ELV shares on 2026-06-11, worth $61K, per SEC Form 4 filings.